CT imaging supplements lab tests for diagnosing coronavirus disease

By Abraham Kim, LabPulse.com contributing writer

February 13, 2020 -- Computed tomography (CT) was able to detect COVID-19, the disease caused by the 2019 novel coronavirus, in individuals with high clinical suspicion of the virus -- even in cases with negative initial DNA tests -- Chinese researchers reported in a study published online February 12 in the journal Radiology.

The group, led by Xingzhi Xie from Central South University in Hunan Province, examined the data of 167 patients suspected of having COVID-19 who underwent a CT exam and DNA testing for the virus, which is known as SARS-CoV-2 or 2019-nCoV. Two thoracic radiologists independently reviewed the CT scans and identified typical imaging findings such as ground-glass opacities, lung consolidation, or both for all of the cases. Clinicians additionally performed DNA analysis of the patients' mouth swab samples using reverse transcription polymerase chain reaction (RT-PCR).

hest CT scans of a 60-year-old male with COVID-19 showing multifocal ground-glass opacities and mixed consolidation in the peripheral area of both lungs. DNA tests returned negative for 2019-nCoV until the eight day after presentation
Chest CT scans of a 60-year-old male with COVID-19 showing multifocal ground-glass opacities and mixed consolidation in the peripheral area of both lungs. DNA tests returned negative for 2019-nCoV until the eight day after presentation. Image courtesy of the RSNA.

After examining the data, the researchers found that the combination of CT and DNA analysis was able to confirm a diagnosis of COVID-19 in the vast majority of the patients (93%). However, in five of the patients (3%), CT scans indicated COVID-19 despite the disease being only weakly positive on initial DNA analysis for one case and entirely ruled out for the other cases.

DNA tests turned out to be negative for the novel coronavirus in multiple cases, contradicting the patients' history of contact with infected individuals and the appearance of common signs suggestive of COVID-19 on their CT scans.

In the case of one 29-year-old man, the initial DNA test was negative for 2019-nCoV and so was the follow-up DNA test performed several days later. His CT scans showed multifocal mixed ground-glass opacities and parenchymal consolidation involving the subpleural regions of both lungs. The patient was not admitted to the hospital for isolated treatment until a third DNA test based on a sample collected eight days after initial presentation turned out positive for the virus.

Current diagnostic criteria regard DNA analysis of swab tests to be a standard and formative assessment for the diagnosis of COVID-19, but the study's results show that DNA tests will occasionally produce false negatives, the authors noted. The limited supply and time-consuming nature of DNA tests, along with their susceptibility to false negatives, underscore the need for improved screening for the early detection of COVID-19 -- a barrier that CT may help resolve.

"In the context of typical clinical presentation and exposure to other individuals with 2019-nCoV, CT features of viral pneumonia may be strongly suspicious for 2019-nCoV infection despite negative RT-PCR results," they concluded. "In these cases, repeat swab testing and patient isolation should be considered."

Chinese officials have decided to expand the diagnostic criteria for COVID-19 to include cases diagnosed based on clinical symptoms and chest CT. As a result, there was a surge in reports for COVID-19, with roughly 15,000 new cases reported between February 12 and 13.

WHO officially names coronavirus disease COVID-19
The World Health Organization (WHO) on February 11 announced an official designation for the disease caused by the novel coronavirus (2019-nCoV), naming...
CDC wrestles with coronavirus test problems in states
The U.S. Centers for Disease Control and Prevention (CDC) reported that there have been problems with some of the 2019-nCoV test kits sent out to labs...
CMS offers guidance on use of CDC coronavirus test
The U.S. Centers for Medicare and Medicaid Services (CMS) on February 6 offered guidance to medical labs in the field on how to use a diagnostic test...
FDA shares CDC test with labs on emergency use basis
In a breakthrough for diagnostics amid the Wuhan coronavirus crisis, the U.S. Food and Drug Administration (FDA) has issued an emergency use authorization...
Laboratories, IVD vendors get to work on novel coronavirus
The emergence of novel viruses underscores the need for laboratories to be vigilant and for IVD vendors to constantly update test menus, writes Bruce...

Copyright © 2020 LabPulse.com

Last Updated np 2/13/2020 3:43:52 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email